Nadal, Ernest http://orcid.org/0000-0002-9674-5554
Bautista, Dolores
Cabezón-Gutiérrez, Luis
Ortega, Ana Laura
Torres, Héctor http://orcid.org/0000-0003-0154-5240
Carcedo, David http://orcid.org/0000-0002-2809-7399
Ruiz de Alda, Lucía
Garcia, J. Francisco
Vieitez, Paula
Rojo, Federico
Funding for this research was provided by:
Roche Pharma
Article History
Received: 14 February 2021
Accepted: 25 May 2021
First Online: 10 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: EN received research grant support from Pfizer, Merk Serono, BMS and Roche and participated in advisory boards from BMS, MSD, Lilly, Roche, Pfizer, Takeda, Boehringer Ingelheim, Amgen and AstraZeneca. FR received research grant support from Pfizer and Roche and received speaker or consulting fees from Roche, BMS, MSD, Merck, Novartis, Pfizer, AstraZeneca, Genomic Health, Bayer. LCG received speaker or consulting fees from Angelini, Grunenthal, Kyowa Kirin, Mudipharma, Pfizer, Roche, Rovi, Leo Pharma, Merck Serono, Ipsen Pharma, Lilly, Amgen, Boehringer Ingelheim, and AstraZeneca. DB. Received research support Roche and AstraZeneca and participated in advisory boards for MSD, Roche, AstraZeneca and Abbvie. HT received grants from Roche and AstraZeneca. ALO received fees for the participation in the study. LrdA, FG and PV are employees of Roche. DC is employee of Hygeia Consulting which received funding from Roche to conduct the analysis.